Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting: The Dutch Experience.

IF 1.7 Q2 SURGERY
Roos de Jong, Monica Gianoli, Maaike Roefs, Sandeep Singh, Patrique Segers, Michiel Voskuil, Pim van der Harst, Willem Suyker, Kirolos Jacob
{"title":"Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting: The Dutch Experience.","authors":"Roos de Jong, Monica Gianoli, Maaike Roefs, Sandeep Singh, Patrique Segers, Michiel Voskuil, Pim van der Harst, Willem Suyker, Kirolos Jacob","doi":"10.1177/15569845261495044","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Hybrid coronary revascularization (HCR) is minimally invasive coronary artery bypass surgery in patients with multivessel disease. This study compared the clinical outcomes of robot-assisted HCR patients with those receiving conventional on-pump coronary artery bypass grafting (CABG) in the Netherlands.</p><p><strong>Methods: </strong>We included 117 HCR and 2,160 CABG patients between January 2015 and December 2021. We performed a 1:3 propensity score matching (PSM) analysis. The primary outcome was the incidence of major adverse cardiac and cerebrovascular events (MACCE) at ≤30 days of follow-up. Secondary outcomes included red blood cell transfusions, length of stay, and the individual components of MACCE, which were mortality, perioperative myocardial infarction, revascularization of the target vessel (TVR), kidney failure, and in-hospital ischemic cerebrovascular accidents. Mortality and TVR at midterm follow-up were also included.</p><p><strong>Results: </strong>After PSM, 115 HCR and 342 on-pump CABG patients were included. HCR patients underwent a mean ± standard deviation of 1 ± 0 distal anastomosis, whereas CABG patients had a mean of 3.6 ± 1.1 distal anastomoses. At ≤30 days of follow-up, no differences in MACCE (odds ratio [OR] = 1.27, 95% confidence interval [CI]: 0.48 to 2.88, <i>P</i> = 0.57) or in the individual secondary outcomes were found. HCR resulted in a shorter hospital stay (OR = 0.99, 95% CI: 0.99 to 1.0, <i>P</i> = 0.02). At a median of 35 months (interquartile range [IQR], 23 to 45) of follow-up in the HCR group and 34 months (IQR, 22 to 45) in the CABG group, all-cause mortality and TVR did not differ.</p><p><strong>Conclusions: </strong>HCR provides excellent short-term and midterm outcomes, comparable to conventional CABG, while also offering faster recovery.</p>","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"15569845261495044"},"PeriodicalIF":1.7000,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15569845261495044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Hybrid coronary revascularization (HCR) is minimally invasive coronary artery bypass surgery in patients with multivessel disease. This study compared the clinical outcomes of robot-assisted HCR patients with those receiving conventional on-pump coronary artery bypass grafting (CABG) in the Netherlands.

Methods: We included 117 HCR and 2,160 CABG patients between January 2015 and December 2021. We performed a 1:3 propensity score matching (PSM) analysis. The primary outcome was the incidence of major adverse cardiac and cerebrovascular events (MACCE) at ≤30 days of follow-up. Secondary outcomes included red blood cell transfusions, length of stay, and the individual components of MACCE, which were mortality, perioperative myocardial infarction, revascularization of the target vessel (TVR), kidney failure, and in-hospital ischemic cerebrovascular accidents. Mortality and TVR at midterm follow-up were also included.

Results: After PSM, 115 HCR and 342 on-pump CABG patients were included. HCR patients underwent a mean ± standard deviation of 1 ± 0 distal anastomosis, whereas CABG patients had a mean of 3.6 ± 1.1 distal anastomoses. At ≤30 days of follow-up, no differences in MACCE (odds ratio [OR] = 1.27, 95% confidence interval [CI]: 0.48 to 2.88, P = 0.57) or in the individual secondary outcomes were found. HCR resulted in a shorter hospital stay (OR = 0.99, 95% CI: 0.99 to 1.0, P = 0.02). At a median of 35 months (interquartile range [IQR], 23 to 45) of follow-up in the HCR group and 34 months (IQR, 22 to 45) in the CABG group, all-cause mortality and TVR did not differ.

Conclusions: HCR provides excellent short-term and midterm outcomes, comparable to conventional CABG, while also offering faster recovery.

混合型冠状动脉重建术与非泵式冠状动脉旁路移植术:荷兰经验。
目的:混合型冠状动脉重建术(HCR)是治疗多血管病变的微创冠状动脉搭桥手术。本研究比较了荷兰机器人辅助HCR患者与接受常规无泵冠状动脉旁路移植术(CABG)患者的临床结果。方法:我们纳入了2015年1月至2021年12月期间117例HCR和2160例CABG患者。我们进行了1:3倾向评分匹配(PSM)分析。主要终点是≤30天随访时主要心脑血管不良事件(MACCE)的发生率。次要结局包括红细胞输注、住院时间和MACCE的各个组成部分,即死亡率、围手术期心肌梗死、靶血管重建术(TVR)、肾功能衰竭和院内缺血性脑血管事故。中期随访时的死亡率和TVR也包括在内。结果:经PSM后,纳入115例HCR和342例无泵CABG患者。HCR患者的远端吻合平均±标准差为1±0,而CABG患者的远端吻合平均为3.6±1.1。在≤30天的随访中,MACCE(优势比[OR] = 1.27, 95%可信区间[CI]: 0.48 ~ 2.88, P = 0.57)或个别次要结局均无差异。HCR导致住院时间缩短(OR = 0.99, 95% CI: 0.99 ~ 1.0, P = 0.02)。HCR组随访中位数为35个月(四分位间距[IQR], 23至45),CABG组随访中位数为34个月(IQR, 22至45),全因死亡率和TVR无差异。结论:HCR提供了极好的短期和中期结果,与传统CABG相当,同时也提供了更快的恢复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
6.70%
发文量
80
期刊介绍: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery is the first journal whose main mission is to disseminate information specifically about advances in technology and techniques that lead to less invasive treatment of cardiothoracic and vascular disease. It delivers cutting edge original research, reviews, essays, case reports, and editorials from the pioneers and experts in the field of minimally invasive cardiothoracic and vascular disease, including biomedical engineers. Also included are papers presented at the annual ISMICS meeting. Official Journal of the International Society for Minimally Invasive Cardiothoracic Surgery
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书